Roy Exum: My Pimples And Andrea Sloan

Monday, September 30, 2013 - by Roy Exum
Roy Exum
Roy Exum

A real long time ago I was having a fit with acne. I was a lovelorn teenager, infatuated with pretty girls in a dizzy game where pimples can really become cumbersome. It seemed like nothing was working and, after I grew a pimple large enough for its own zip code, I finally found a genius doctor who quickly became my lifelong hero when he came up with a marvelous idea.

At the time there was a new “super drug”  that was languishing through years of “clinical trials” in the United States and nobody could get any, despite the fact the revolutionary medicine was already available in Germany. My hero called up a close friend who was a German doctor and – presto! – the first 250 pills came flying across the ocean.

I had to promise that I would not sue anybody if I grew an extra set of ears, developed female breasts, or my eyes turned yellow, but, honestly, I would have dyed my hair green to get the American-made medicine. After I took a course of what was then identified by only a strange laboratory number, my pimples and my acne were gone forever. I had Clark Gable looks and never looked back. That’s a true story (except the Gable part.)

Other fellow Americans had to wait for many months. I don’t believe that's right. Since this occurred in my formative years, I have cursed the federal Food and Drug Administration for much of my adult life because the “clinical trials” process we use is horribly dysfunctional and in critical need of an overhaul.

To illustrate my point, allow me to introduce a beautiful Texas lawyer, Andrea Sloan. Yes, she is quite pretty but “beautiful” because her career has been as the executive director of a Texas advocacy project that provides free legal services to low-income victims of domestic or sexual abuse.

Andrea is a victim herself, not just of stage 3c ovarian cancer but a horribly-tangled FDA system. Her doctors have exhausted every known method to save her life. Six years of surgery, radiation, and chemotherapy haven’t worked. She’s still very much a patient at the world-famous M.D. Anderson Medical Center and her oncologist believes an experimental drug called “BMN 673” might well save Andrea’s life.

M.D. Anderson has a good supply of BMN 673 on hand but with millions of dollars at stake, the manufacturer, BioMarin in California, has said no. “It would be unethical and reckless to provide end-stage refractory ovarian cancer patients outside clinical trial with BMN 673 at this early stage of development,” said spokesperson Debra Charlesworth.

“If we did,” Charlesworth explained to CNN, “we would be exposing the experimental drug to a large group without adequate testing. There have been previous circumstances where early access to large groups has resulted in adverse consequences that were worse than the course of the disease.”

I am certain no scientist can hardly wait for somebody to try to explain to me what “adverse consequences” could possibly be worse than what Andrea Sloan is facing without BMN 673. Andrea is pleading for the drug – let the petals of the flower fall where they may – and probably understands the risks as much as anyone involved. She knows what will happen if she fails to get BMN 673 better than anyone else, too.

Here is what she wrote in a statement to the drug company: “I recognize the importance of weighing the risk and the myriad of considerations they face as a company. However, this is a risk worth taking. I will thank them. My family will thank them. An amazing army of loyal supporters, to whom I owe a debt of gratitude, will thank them. In America we do not leave our wounded warriors on the battleground. BioMarin, please be the Calvary that saves me.”

Her M.D. Anderson doctors believe Andrea is a great candidate. Further, the FDA itself has just announced Ms. Sloan qualifies for a “compassionate care” waiver in the rules but the manufacturer, BioMarin, still says no. The word is BioMarin stands to make about $500 million on the drug and, even though they say they plan to give away 10 percent of the medicine to charity, they refuse to face the ethical dilemma.

As of Sunday afternoon Andrea had almost 170,000 supporters on her Change.org webpage and politician Newt Gingrich, co-host of CNN’s “Crossfire” program, is irate at “a corporation protecting its wallet at the expense on Andrea’s possibly dying. If you want to know why big companies often get bad names, it’s explaining that clerical support to fill out FDA paperwork is too difficult when you can save a life.”

Dr. Charles Levenback, Andrea’s doctor, is disappointed at BioMarin’s stance but, as a man who sees the fight against cancer every day, he told CNN reporters, “My own belief is that the drug companies, the manufacturers, the insurance companies, the providers like my hospital M.D. Anderson, the individual medical professionals, the investigators, the patients -- everybody wants the same things. Safe, effect, novel therapies for as many people as it's appropriate for. Even BioMarin, I believe. I don't think this is like 'Let the masses eat cake.' I think they're on the same mission. But the whole system is giving this dysfunctional result."

On Andrea Sloan’s Facebook page there is a picture that tells of “Three Simple Rules.” The text reads, “If you don’t go after what you want in life, you will never have it. If you don’t ask, the answer will always be No. If you don’t step forward, you’ll always be in the same place.”

Those three rules got rid of my pimples but all we can do is pray for Andrea Sloan. She needs it right now.

royexum@aol.com


2 Constitution Amendments Needed

I have just sent my federal and state representatives the following message:  "Dear ...,   First, let me thank you for your service.  Since the Declaration of Independence lists life as the first inalienable right and since the family is the fundamental unit of society and in accordance with Article V of the U.S. Constitution, I would respectfully request ... (click for more)

Roy Exum: Dr. Tydings Is A Winner

One week from tomorrow the most important educator in the future of our community will start work as the new president of Chattanooga State. While I am normally cynical of beard-strokers and foundation-hungry dreamers who have little or no concept of the real world, I am convinced Flora Tydings will become the best thing to happen in our community in years. A grandmother with ... (click for more)

Bradley County Commission Rejects 10-Cent Tax Rise For Lake Forest MS; Firefighters Get $3,000 Raise

With a small crowd of demonstrators sitting in the back of the room with signs that read, “Vote no on property tax increase,” the Bradley County Commission on Monday night finally rejected a proposed 10-cent property tax increase that would have added funds to the construction of a new academic building at Lake Forest Middle School.   Funding for renovations at ... (click for more)

11 Attorneys Apply In 2nd Round For Replacing Judge Stern

Eleven attorneys have applied in the second round of applications to replace Rebecca Stern as judge of Criminal Court's Division II. The applicants are: Christian J. Coder Chattanooga Tracy Cox Signal Mountain Amanda B. Dunn Chattanooga Ardena Juanita Garth Chattanooga Thomas Clifton Greenholtz Ooltewah Andrea DeFay Hayduk ... (click for more)

Dalton Edges Stuart Heights To Conclude Unbeaten Regular Season

The Dalton Dolphins had several key goals when the 2015 Chattanooga Area Swim League season began on the first day of June and they can put a big check mark by the first one, which was to go undefeated in the ever-competitive Blue division. They accomplished that goal before dark on Monday as they defeated a much-improved Stuart Heights squad by a 404-386 final that may have ... (click for more)

Chattanooga Hosts Nashville Friday In NPSL Playoffs

Chattanooga will host this weekend's National Premier Soccer League Southeast Conference playoffs. There are two semifinal matches on Friday with the two winners meeting in the Championship match the following night. “We’re very proud of the team for winning home field advantage,” said board member Krue Brock. “Now that every game is a must-win situation, it will be a big help ... (click for more)